J Ache Res. 2018;11:1273-1279
Authors: Raeissadat SA, Rayegani SM, Sadeghi F, Rahimi-Dehgolan S
Function: Myofascial ache syndrome (MPS) is a standard musculoskeletal dysfunction amongst younger adults related to presence of myofascial set off factors. We aimed to guage efficacy of ozone injection (OI) in MPS sufferers, in contrast with two at the moment used strategies together with lidocaine injection (LI) and dry needling (DN).
Sufferers and strategies: On this single-blinded research, a complete of 72 eligible sufferers have been included after which randomly divided into three equal teams: DN, OI, and LI. All sufferers acquired remedy in three weekly periods. Visible analog scale (VAS) for ache, cervical lateral flexion, ache strain threshold (PPT), and neck incapacity index (NDI) have been the principle final result measures, which have been evaluated at baseline and at four weeks after injections. Analytic outcomes have been demonstrated as each within- and between-groups imply distinction (MD).
Outcomes: Sixty two sufferers completed the research, 20 individuals in each the DN and LI teams, and 22 individuals in OI group. Distribution of all demographics and baseline scientific variables have been comparatively comparable amongst teams. All three interventions have been remarkably efficient in enhancing sufferers’ ache and PPT. Important lower in VAS (MD=-Three.6±1.four) and enhance in PPT (MD=7.2±5.1) inside four weeks follow-up confirmed this discovering. Additionally, NDI had comparable important enchancment (MD=-9.9±eight.7), however lateral flexion vary didn’t present exceptional enhance. There was additionally a statistically important distinction amongst three strategies’ efficacy on VAS, NDI, and PPT, favoring OI and LI.
Conclusion: In abstract, this information confirmed that in short-term follow-up, all three strategies have been considerably efficient in MPS remedy; nevertheless, OI and LI teams had barely higher outcomes than the DN group, with no exceptional choice between them.
PMID: 29988746 [PubMed]